Cencora Inc. (COR)
NYSE: COR
· Real-Time Price · USD
307.05
8.23 (2.75%)
At close: Sep 26, 2025, 3:59 PM
307.00
-0.02%
After-hours: Sep 26, 2025, 06:16 PM EDT
Cencora Revenue Breakdown
| Period Ending | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Office Light Industrial And Other Revenue Revenue | 2.51M | 2.56M | 2.54M | 2.54M | 2.77M | 2.96M | 3.21M | 3.05M | 2.63M | 2.88M | 3.05M |
| Office Light Industrial And Other Revenue Revenue Growth | -2.15% | +0.95% | -0.04% | -8.44% | -6.38% | -7.79% | +5.38% | +16.03% | -8.76% | -5.67% | n/a |
| Rental Power And Related Revenue Revenue | 132.98M | 130.43M | 130.3M | 127.11M | 124.5M | 123.6M | 122.6M | 121.08M | 117.85M | n/a | n/a |
| Rental Power And Related Revenue Revenue Growth | +1.95% | +0.10% | +2.51% | +2.09% | +0.73% | +0.81% | +1.25% | +2.74% | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|
| International Healthcare Solutions Revenue | 7.79B | 7.46B | 21.58B | 7.05B |
| International Healthcare Solutions Revenue Growth | +4.47% | -65.44% | +205.96% | n/a |
| U.S. Healthcare Solutions Revenue | 72.88B | 74.03B | 198.15B | 67.19B |
| U.S. Healthcare Solutions Revenue Growth | -1.56% | -62.64% | +194.90% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.67B | 1.6B | 1.47B | 1.49B | 1.38B | 1.39B | 1.4B | 1.39B | 1.3B | 1.32B | 1.29B | 1.26B | 1.21B | 1.2B | 1.17B | 1.22B | 913.41M | 730.08M | 735.07M | 720.97M | 666.88M | 693.41M | 685.95M | 721.94M | 656.94M | 628.04M | 656.59M | 657.8M | 626.55M | 617.43M | 558.52M | 560.88M | 525.46M | 521.84M | 520.55M | 530.26M | 18.65M | 18.36M | 19.22M | 17.86M | 17.21M | 16.89M |
| Selling, General, and Administrative Revenue Growth | +4.55% | +8.69% | -1.23% | +7.75% | -0.40% | -0.71% | +0.35% | +6.88% | -1.28% | +2.34% | +2.17% | +4.23% | +0.74% | +2.83% | -3.75% | +33.09% | +25.11% | -0.68% | +1.96% | +8.11% | -3.83% | +1.09% | -4.99% | +9.89% | +4.60% | -4.35% | -0.19% | +4.99% | +1.48% | +10.55% | -0.42% | +6.74% | +0.69% | +0.25% | -1.83% | +2742.74% | +1.61% | -4.48% | +7.62% | +3.74% | +1.92% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |